Task: Answer the multiple-choice question.
Question: Which drug exhibits a -10.985\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: CC(C)CN1C(=O)c2ccc(C(=O)NCc3ccccn3)cc2C1=O
b: CCCC1c2ccsc2CCN1C(=S)NC
c: Cc1cc(C)c(NC(=O)COC(=O)CCn2c(C)csc2=O)c(C)c1
d: CCCCN(C)S(=O)(=O)c1cc2c3c(c1)CCC(=O)N3CCC2
e: COc1ccc(CC(=O)NCc2n[nH]c(=S)n2-c2ccccc2OC)cc1
Answer: d. CCCCN(C)S(=O)(=O)c1cc2c3c(c1)CCC(=O)N3CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C)S(=O)(=O)c1cc2c3c(c1)CCC(=O)N3CCC2
CCCCN(C)S(=O)(=O)c1cc2c3c(c1)CCC(=O)N3CCC2
N-butyl-N-methyl-2-oxo-1-azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-triene-7-sulfonamide